alexa Nan Mei | National Center for Toxicological Research
ISSN: 2153-0645

Journal of Pharmacogenomics & Pharmacoproteomics
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
 
 

Nan Mei

Nan Mei Nan Mei
Division of Genetic and Reproductive Toxicology
National Center for Toxicological Research
U.S. Food and Drug Administration
USA
Biography

Nan Mei is a Senior Research Biologist in the Division of Genetic and Molecular Toxicology at the US FDA National Center for Toxicological Research, NCTR. He received his MD in 1984 from Hebei Medical University China and earned his PhD degree in 1997 at the University of Occupational and Environmental Health, Japan. He has published 58 peer reviewed research articles in prestigious journals including The FASEB Journal Nature Biotechnology, Journal of Biological Chemistry, British Journal of Cancer, Cancer Letters, Toxicological Sciences, Toxicology in Vitro Chemical Research in Toxicology Mutation Research Environmental and Molecular Mutagenesis and BMC Bioinformatics. He was author of 7 book chapters. He is a member of the Society of Toxicology and the Environmental Mutagen Society. He served as a reviewer of many peer reviewed journals in the area of genetic toxicology and toxicogenomics. He received many awards including the 2007 FDA Scientific Achievement Award.

Research Interest

Currently he focuses his research on genetic toxicology and toxicogenomics. He utilizes the in vivo and in vitro mutation assays to evaluate a number of high-priority chemicals for their mutagenicity and to determine the mechanisms of chemical-induced genetic toxicity. His interests include the evaluation of the mutagenic effects of direct mutagens, botanical chemicals, herbal dietary supplements, industrial compounds, and ingredients in cosmetics and other retail products. He incorporates toxicogenomic approaches into his research to develop potential biomarkers, create gene signatures, and elucidate molecular mechanisms.

Certificate
Certificate

Global Speakers in the subject

Global Experts in the subject

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords